{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:08Z","timestamp":1787163848675,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T00:00:00Z","timestamp":1497830400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00066-017-1166-1","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T07:40:44Z","timestamp":1497858044000},"page":"943-950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Proton therapy of iris melanoma with 50\u00a0CGE","Protonentherapie des Irismelanoms mit 50 CGE"],"prefix":"10.1007","volume":"193","author":[{"given":"Aline I.","family":"Riechardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Karle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Cordini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Heufelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Budach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia M.","family":"Joussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Gollrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"1166_CR1","first-page":"57","volume-title":"Ocular tumours: Diagnosis and treatment","author":"B Damato","year":"2000","unstructured":"Damato B (2000) Uveal melanoma. In: Ocular tumours: Diagnosis and treatment. Butterworth-Heimann, Oxford, pp 57\u201393"},{"key":"1166_CR2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0002-9394(14)76028-3","volume":"99","author":"LJ Geisse","year":"1985","unstructured":"Geisse LJ, Robertson DM (1985) Iris melanomas. Am J Ophthalmol 99:638\u2013648","journal-title":"Am J Ophthalmol"},{"key":"1166_CR3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0161-6420(00)00449-8","volume":"108","author":"CL Shields","year":"2001","unstructured":"Shields CL, Shields JA, Materin M et\u00a0al (2001) Iris melanoma: Risk factors for metastasis in 169 consecutive patients. Ophthalmology 108:172\u2013178","journal-title":"Ophthalmology"},{"key":"1166_CR4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bjo.85.7.848","volume":"85","author":"RM Conway","year":"2001","unstructured":"Conway RM, Chua WC, Qureshi C, Billson FA (2001) Primary iris melanoma: Diagnostic features and outcome of conservative surgical treatment. Br J Ophthalmol 85:848\u2013854","journal-title":"Br J Ophthalmol"},{"key":"1166_CR5","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0161-6420(96)30392-8","volume":"103","author":"GO Naumann","year":"1996","unstructured":"Naumann GO, Rummelt V (1996) Block excision of tumors of the anterior uvea: Report on 68 consecutive patients. Ophthalmology 103:2017\u20132027","journal-title":"Ophthalmology"},{"key":"1166_CR6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bjo.79.4.306","volume":"79","author":"CL Shields","year":"1995","unstructured":"Shields CL, Shields JA, De Potter P et al (1995) Treatment of non-resectable malignant iris tumours with custom designed plaque radiotherapy. Br J Ophthalmol 79:306\u2013312","journal-title":"Br J Ophthalmol"},{"key":"1166_CR7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0002-9394(01)01007-8","volume":"132","author":"PT Finger","year":"2001","unstructured":"Finger PT (2001) Plaque radiation therapy for malignant melanoma of the iris and ciliary body. Am J Ophthalmol 132:328\u2013335","journal-title":"Am J Ophthalmol"},{"key":"1166_CR8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/bjophthalmol-2013-303321","volume":"98","author":"MT Sandinha","year":"2014","unstructured":"Sandinha MT, Kacperek A, Errington RD et\u00a0al (2014) Recurrence of iris melanoma after proton beam therapy. Br J Ophthalmol 98:484\u2013487","journal-title":"Br J Ophthalmol"},{"key":"1166_CR9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bjophthalmol-2012-302659","volume":"97","author":"L Konstantinidis","year":"2013","unstructured":"Konstantinidis L, Roberts D, Errington RD et\u00a0al (2013) Whole anterior segment proton beam radiotherapy for diffuse iris melanoma. Br J Ophthalmol 97:471\u2013474","journal-title":"Br J Ophthalmol"},{"key":"1166_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2005.01.050","volume":"63","author":"B Damato","year":"2005","unstructured":"Damato B, Kacperek A, Chopra M et\u00a0al (2005) Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys 63:109\u2013115","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1166_CR11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00066-016-1005-9","volume":"192","author":"SB Harrabi","year":"2016","unstructured":"Harrabi SB, Bougatf N, Mohr A et al (2016) Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma. Strahlenther Onkol 192:759\u2013769","journal-title":"Strahlenther Onkol"},{"key":"1166_CR12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00066-015-0878-3","volume":"191","author":"K Gurtner","year":"2015","unstructured":"Gurtner K, Baumann M (2015) Proton therapy of pediatric rhabdomyosarcoma: Same tumor control as photon therapy, with less adverse effects. Strahlenther Onkol 191:814\u2013816","journal-title":"Strahlenther Onkol"},{"key":"1166_CR13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2016.01.040","volume":"95","author":"J Hrbacek","year":"2016","unstructured":"Hrbacek J, Mishra KK, Kacperek A et\u00a0al (2016) Practice patterns analysis of ocular proton therapy centers: the international OPTIC survey. Int J Radiat Oncol Biol Phys 95:336\u2013343","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1166_CR14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/bjophthalmol-2014-305174","volume":"99","author":"GD Willerding","year":"2015","unstructured":"Willerding GD, Cordini D, Hackl C et\u00a0al (2015) Proton beam radiotherapy of diffuse iris melanoma in 54 patients. Br J Ophthalmol 99:812\u2013816","journal-title":"Br J Ophthalmol"},{"key":"1166_CR15","volume-title":"TNM classification of malignant tumours","author":"LH Sobin","year":"2009","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours, 7th\u00a0edn. Wiley-Blackwell, Oxford","edition":"7"},{"key":"1166_CR16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1118\/1.595258","volume":"10","author":"M Goitein","year":"1983","unstructured":"Goitein M, Miller T (1983) Planning proton therapy of the eye. Med Phys 10:275\u2013283","journal-title":"Med Phys"},{"key":"1166_CR17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1088\/0031-9155\/47\/4\/304","volume":"47","author":"B Dobler","year":"2002","unstructured":"Dobler B, Bendl R (2002) Precise modeling of the eye for proton therapy of intra-ocular tumours. Phys Med Biol 47:593\u2013613","journal-title":"Phys Med Biol"},{"key":"1166_CR18","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.eye.6702102","volume":"20","author":"L Lumbroso-Le Rouic","year":"2006","unstructured":"Lumbroso-Le Rouic L, Delacroix S, Dendale R et al (2006) Proton beam therapy for iris melanomas. Eye 20:1300\u20131305","journal-title":"Eye"},{"key":"1166_CR19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","volume":"87","author":"KK Mishra","year":"2013","unstructured":"Mishra KK, Daftari IK, Weinberg V et al (2013) Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a\u00a0detailed analysis of tumor and dose-volume parameters. Int J Radiat Oncol Biol Phys 87:330\u2013336","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1166_CR20","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00417-014-2735-y","volume":"252","author":"A Rahmi","year":"2014","unstructured":"Rahmi A, Mammar H, Thariat J et\u00a0al (2014) Proton beam therapy for presumed and confirmed iris melanomas: a\u00a0review of 36 cases. Graefes Arch Clin Exp Ophthalmol 252:1515\u20131521","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1166_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.eye.6702132","volume":"21","author":"P Rundle","year":"2007","unstructured":"Rundle P, Singh AD, Rennie I (2007) Proton beam therapy for iris melanoma: a\u00a0review of 15 cases. Eye 21:79\u201382","journal-title":"Eye"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-017-1166-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-017-1166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-017-1166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T10:45:12Z","timestamp":1508841912000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-017-1166-1"}},"subtitle":["Influence of target volume on clinical outcome","Einfluss des Zielvolumens auf das klinische Ergebnis"],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1007\/s00066-017-1166-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]}}}